- Published at
- by markets.businessinsider.com
mixed
mixed
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju...
STSAPFENOVNIKTFGEN.MXFGENCYTRAXP.DEAPTOAPS.TOAPLTALXN0QZM.L0IL8.L0I5R.L0A4P.LYMTXVX1.DEVRTX34.SAVRTX.MXVRTXSPRBRXDXRDYPHGUFPHARM.ASPHARPFED.BAPFECL.SNPFE.MXPFE.DEORICNTUSMSONLMATHAPPELANDRREDDY.NSDRREDDY.BODMTKWDMTK.MXDMTKCVACAPOPWAPOP0QZU.LZTS.MXZTSZOE.DEZ1TS34.SASWAVSUPNPTGXKINIDP.DEGNMSFGMABN.MXGMABCVACN.MXCTXRWCTXRBPMCBIIBD.BABIIBCL.SNBIIB.SNBIIB.MXBIIB.BABIIBALZNABCL5CV.DE0M3Q.L0LB2.L